A carregar...

Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey

INTRODUCTION: Imraldi™ is a biosimilar of the anti-tumor necrosis factor (TNF) monoclonal antibody adalimumab and was recently approved in Europe for the treatment of various inflammatory conditions. Imraldi is administered via an autoinjector device that features distinct design attributes compared...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatol Ther
Main Authors: Fenwick, Steve, Thakur, Kunal, Munro, Duncan
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514039/
https://ncbi.nlm.nih.gov/pubmed/30790242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-019-0144-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!